Crestline Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,949
Closed -$1.18M 504
2024
Q4
$1.18M Buy
+27,949
New +$1.18M 0.04% 381